UNSPSC 85265603: Diagnosis of mixed hyperlipidaemia

This classification denotes the group of activities that yields a diagnosis of Mixed hyperlipidaemia. Mixed hyperlipidaemia is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code E78. 2

UNSPSC 85265603 Diagnosis of mixed hyperlipidaemia (Commodity) does not map cleanly to the recent state and local procurement activity tagged under it. The three most recent opportunities—a diagnostic imaging PACS system, ultrasound equipment procurement, and blood draw services for a police department—represent clinical diagnostic and phlebotomy work rather than laboratory testing or lipid panel analysis as the code's title suggests. State and local health systems and public agencies are soliciting diagnostic imaging infrastructure, portable ultrasound platforms, and phlebotomy staffing under this code, reflecting how procurement taxonomy can diverge from clinical nomenclature when jurisdictions apply codes to health services broadly.

The issuing bodies include a county public hospital system (San Mateo Medical Center), a county procurement division supporting clinical services (Collier County, Florida), and a municipal police department's scientific evidence division (Albuquerque Police Department). San Mateo Medical Center's RFP for Diagnostic Imaging PACS posted July 9, 2026, with proposals due August 7, 2026, requires enterprise-grade picture archiving and communication system implementation supporting radiology, cardiology, and dental imaging with EPIC Electronic Health Record integration, 99.9% uptime, and 9–12 month implementation. Collier County issued a Notice of Intent to Single Source EchoNous, Inc. on April 1, 2026, for KOSMOS platform ultrasound equipment with a 5-year product warranty. The Albuquerque Police Department issued a Request for Bids (RFB-2025-748-POL-DZ) on January 26, 2026, for on-call blood draw services with 24/7/365 coverage and a response deadline of February 25, 2026. Geographic activity spans California, Florida, and New Mexico, with no clear concentration pattern evident from three disparate solicitations. The code shows minimal coherent activity under its stated clinical diagnostic intent.